Showing 1 - 9 results of 9 for search 'Sara Oppi', query time: 0.03s Refine Results
  1. 1
    COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?

    COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied? by Antonio Macciò, Sara Oppi, Clelia Madeddu

    Published 2021-02-01
    Get full text
    Article
  2. 2
    Cachexia as Evidence of the Mechanisms of Resistance and Tolerance during the Evolution of Cancer Disease

    Cachexia as Evidence of the Mechanisms of Resistance and Tolerance during the Evolution of Cancer Disease by Antonio Maccio, Elisabetta Sanna, Manuela Neri, Sara Oppi, Clelia Madeddu

    Published 2021-03-01
    Get full text
    Article
  3. 3
    Diagnostic Framework of Pelvic Massive Necrosis with Peritonitis following Chemoradiation for Locally Advanced Cervical Cancer: When Is the Surgery Not Demandable? A Case Report and Literature Review

    Diagnostic Framework of Pelvic Massive Necrosis with Peritonitis following Chemoradiation for Locally Advanced Cervical Cancer: When Is the Surgery Not Demandable? A Case Report an... by Elisabetta Sanna, Giacomo Chiappe, Fabrizio Lavra, Sonia Nemolato, Sara Oppi, Antonio Macciò, Clelia Madeddu

    Published 2022-02-01
    Get full text
    Article
  4. 4
    Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report

    Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Repo... by Clelia Madeddu, Elisabetta Sanna, Sonia Nemolato, Olga Mulas, Sara Oppi, Mario Scartozzi, Giorgio La Nasa, Antonio Maccio

    Published 2022-08-01
    Get full text
    Article
  5. 5
    Decrease in Neutrophil-to-Lymphocyte Ratio during Neoadjuvant Chemotherapy as a Predictive and Prognostic Marker in Advanced Ovarian Cancer

    Decrease in Neutrophil-to-Lymphocyte Ratio during Neoadjuvant Chemotherapy as a Predictive and Prognostic Marker in Advanced Ovarian Cancer by Elisabetta Sanna, Luciana Tanca, Cristina Cherchi, Giulia Gramignano, Sara Oppi, Maria Gloria Chiai, Antonio Macciò, Clelia Madeddu

    Published 2021-07-01
    Get full text
    Article
  6. 6
    Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literature

    Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literatur... by Antonio Macciò, Clelia Donisi, Elisabetta Sanna, Giacomo Chiappe, Sonia Nemolato, Luca Melis, Sara Oppi, Brunella Mola, Clelia Madeddu

    Published 2021-11-01
    Get full text
    Article
  7. 7
    Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine

    Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine by Andrea Galitzia, Luca Barabino, Roberta Murru, Giovanni Caocci, Marianna Greco, Giancarlo Angioni, Olga Mulas, Sara Oppi, Stefania Massidda, Alessandro Costa, Giorgio La Nasa

    Published 2022-07-01
    Get full text
    Article
  8. 8
    The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma

    The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma by Giorgio La Nasa, Marianna Greco, Roberto Littera, Sara Oppi, Ivana Celeghini, Rossella Caria, Sara Lai, Rita Porcella, Massimo Martino, Alessandra Romano, Francesco Di Raimondo, Andrea Gallamini, Carlo Carcassi, Giovanni Caocci

    Published 2016-03-01
    Get full text
    Article
  9. 9
    Genetic deletion of hepatic NCOR1 protects from atherosclerosis by promoting alternative bile acid-metabolism and sterol excretion

    Genetic deletion of hepatic NCOR1 protects from atherosclerosis by promoting alternative bile acid-metabolism and sterol excretion by Martin Geiger, Sara Oppi, Stefanie Nusser-Stein, Sarah Costantino, Shafeeq Ahmed Mohammed, Era Gorica, Joanne A. Hoogerland, Christian M. Matter, Ana T. Guillaumon, Frank Ruschitzka, Francesco Paneni, Maaike H. Oosterveer, Sokrates Stein

    Published 2023-06-01
    Get full text
    Article

Search Tools: